Nectar Lifesciences Limited (NECLIFE.NS)
INR 21.88
(-3.48%)
INR 21.88
(-3.48%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 4.82 Billion INR | -7.24% |
| 2022 | 3.64 Billion INR | 21.73% |
| 2021 | 2.99 Billion INR | 16.21% |
| 2020 | 2.57 Billion INR | -30.16% |
| 2019 | 3.68 Billion INR | -10.49% |
| 2018 | 4.12 Billion INR | 12.83% |
| 2017 | 3.65 Billion INR | 0.94% |
| 2016 | 3.61 Billion INR | -9.18% |
| 2015 | 3.98 Billion INR | 3.16% |
| 2014 | 3.86 Billion INR | 0.35% |
| 2013 | 3.84 Billion INR | -1.06% |
| 2012 | 3.88 Billion INR | 23.84% |
| 2011 | 3.14 Billion INR | 4.22% |
| 2010 | 3.01 Billion INR | -65.61% |
| 2009 | 8.76 Billion INR | 11.32% |
| 2008 | 7.87 Billion INR | 2.92% |
| 2007 | 7.64 Billion INR | 58.51% |
| 2006 | 4.82 Billion INR | 62.33% |
| 2005 | 2.97 Billion INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 825.1 Million INR | -12.97% |
| 2023 Q1 | 1.14 Billion INR | 18.17% |
| 2023 FY | 3.38 Billion INR | -7.24% |
| 2023 Q4 | 948.07 Million INR | 7.97% |
| 2023 Q3 | 878.11 Million INR | -20.29% |
| 2023 Q2 | 1.1 Billion INR | -4.16% |
| 2022 Q3 | 737.13 Million INR | -7.85% |
| 2022 Q1 | 1.13 Billion INR | 675.29% |
| 2022 FY | 3.64 Billion INR | 21.73% |
| 2022 Q2 | 799.94 Million INR | -29.46% |
| 2022 Q4 | 972.75 Million INR | 31.97% |
| 2021 FY | 2.99 Billion INR | 16.21% |
| 2021 Q4 | -197.13 Million INR | -116.71% |
| 2021 Q3 | 1.17 Billion INR | 17.41% |
| 2021 Q2 | 1 Billion INR | -0.17% |
| 2021 Q1 | 1 Billion INR | 556.16% |
| 2020 FY | 2.57 Billion INR | -30.16% |
| 2020 Q2 | 972.3 Million INR | 16.61% |
| 2020 Q1 | 833.82 Million INR | 765.73% |
| 2020 Q4 | -220.6 Million INR | -122.28% |
| 2020 Q3 | 990.17 Million INR | 1.84% |
| 2019 Q3 | 1.25 Billion INR | 2.13% |
| 2019 Q4 | -125.24 Million INR | -109.95% |
| 2019 Q2 | 1.23 Billion INR | -6.82% |
| 2019 FY | 3.68 Billion INR | -10.49% |
| 2019 Q1 | 1.32 Billion INR | 9035.14% |
| 2018 Q2 | 1.37 Billion INR | 7.15% |
| 2018 Q1 | 1.28 Billion INR | 0.0% |
| 2018 FY | 4.12 Billion INR | 12.83% |
| 2018 Q4 | 14.47 Million INR | -99.0% |
| 2018 Q3 | 1.44 Billion INR | 5.11% |
| 2017 FY | 3.65 Billion INR | 0.94% |
| 2016 FY | 3.61 Billion INR | -9.18% |
| 2015 Q3 | - INR | 0.0% |
| 2015 FY | 3.98 Billion INR | 3.16% |
| 2015 Q4 | - INR | 0.0% |
| 2014 FY | 3.86 Billion INR | 0.35% |
| 2014 Q4 | - INR | 0.0% |
| 2014 Q3 | - INR | 0.0% |
| 2013 FY | 3.84 Billion INR | -1.06% |
| 2012 FY | 3.88 Billion INR | 23.84% |
| 2011 FY | 3.14 Billion INR | 4.22% |
| 2010 FY | 3.01 Billion INR | -65.61% |
| 2009 FY | 8.76 Billion INR | 11.32% |
| 2008 FY | 7.87 Billion INR | 2.92% |
| 2007 FY | 7.64 Billion INR | 58.51% |
| 2006 FY | 4.82 Billion INR | 62.33% |
| 2005 FY | 2.97 Billion INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | 81.99% |
| Hester Biosciences Limited | 1.27 Billion INR | -278.698% |
| Aarti Drugs Limited | 8.31 Billion INR | 42.001% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | 17.287% |
| Albert David Limited | 1.4 Billion INR | -242.542% |
| Alembic Limited | 1 Billion INR | -382.277% |
| Alkem Laboratories Limited | 52.29 Billion INR | 90.777% |
| Bafna Pharmaceuticals Limited | 452.15 Million INR | -966.738% |
| Bajaj HealthCare Limited | 1.47 Billion INR | -227.712% |
| Biofil Chemicals and Pharmaceuticals Limited | 12.54 Million INR | -38347.908% |
| Brooks Laboratories Limited | 65.62 Million INR | -7250.335% |
| Eris Lifesciences Limited | 10.42 Billion INR | 53.741% |
| FDC Limited | 6.58 Billion INR | 26.767% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | 61.206% |
| Gufic Biosciences Limited | 4.07 Billion INR | -18.4% |
| Hikal Limited | 5.95 Billion INR | 19.045% |
| Ind-Swift Limited | 2.17 Billion INR | -122.012% |
| Innova Captab Limited | 3.46 Billion INR | -39.223% |
| IOL Chemicals and Pharmaceuticals Limited | 4.71 Billion INR | -2.208% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -639.1% |
| Jubilant Pharmova Limited | 19.64 Billion INR | 75.445% |
| Lincoln Pharmaceuticals Limited | 1.88 Billion INR | -155.624% |
| Lupin Limited | 125.09 Billion INR | 96.144% |
| Mangalam Drugs & Organics Limited | 691.19 Million INR | -597.821% |
| Medico Remedies Limited | 262.14 Million INR | -1739.939% |
| Morepen Laboratories Limited | 6.16 Billion INR | 21.716% |
| Orchid Pharma Limited | 2.32 Billion INR | -107.873% |
| Procter & Gamble Health Limited | 5.78 Billion INR | 16.572% |
| RPG Life Sciences Limited | 2.48 Billion INR | -94.253% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -677.352% |
| Sigachi Industries Limited | 2 Billion INR | -140.89% |
| Solara Active Pharma Sciences Limited | -1.65 Billion INR | 391.279% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | -16.977% |
| Themis Medicare Limited | 2.42 Billion INR | -99.309% |
| Unichem Laboratories Limited | 4.86 Billion INR | 0.856% |
| Vaishali Pharma Limited | 90.32 Million INR | -5240.046% |
| Wanbury Limited | 1.73 Billion INR | -178.699% |
| Windlas Biotech Limited | 1.33 Billion INR | -260.27% |
| ZIM Laboratories Limited | 1.26 Billion INR | -280.442% |
| Ind-Swift Laboratories Limited | 4.13 Billion INR | -16.696% |
| Ipca Laboratories Limited | 48.58 Billion INR | 90.072% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 98.134% |
| Venus Remedies Limited | 2.18 Billion INR | -120.99% |
| Sakar Healthcare Limited | 699.58 Million INR | -589.45% |
| Aurobindo Pharma Limited | 109.54 Billion INR | 95.597% |
| Divi's Laboratories Limited | 32.44 Billion INR | 85.132% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | 22.489% |
| Mankind Pharma Limited | 42.19 Billion INR | 88.57% |
| Sequent Scientific Limited | 2.97 Billion INR | -61.924% |
| Laurus Labs Limited | 15.44 Billion INR | 68.779% |
| Neuland Laboratories Limited | 8.24 Billion INR | 41.521% |
| J. B. Chemicals & Pharmaceuticals Limited | 15.25 Billion INR | 68.39% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 93.044% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 96.148% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -130.335% |
| Wockhardt Limited | 7.72 Billion INR | 37.522% |
| Bal Pharma Limited | 770.19 Million INR | -526.243% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 97.052% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | -30.52% |
| Par Drugs and Chemicals Limited | 529.13 Million INR | -811.541% |
| Caplin Point Laboratories Limited | 9.2 Billion INR | 47.61% |
| Shilpa Medicare Limited | 3.56 Billion INR | -35.414% |
| Valiant Laboratories Limited | 138.02 Million INR | -3394.403% |
| Ajanta Pharma Limited | 21.06 Billion INR | 77.102% |
| Aarey Drugs & Pharmaceuticals Limited | 113.02 Million INR | -4167.303% |
| Granules India Limited | 16.79 Billion INR | 71.289% |
| Medicamen Biotech Limited | 495.49 Million INR | -873.429% |
| Syncom Formulations (India) Limited | 559.5 Million INR | -762.067% |
| Piramal Enterprises Limited | 8.04 Billion INR | 40.033% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 89.684% |
| NATCO Pharma Limited | 25.73 Billion INR | 81.259% |
| Suven Life Sciences Limited | -200.79 Million INR | 2502.073% |
| Krebs Biochemicals & Industries Limited | -108.74 Million INR | 4535.332% |
| Strides Pharma Science Limited | 14.38 Billion INR | 66.477% |
| Indoco Remedies Limited | 8.04 Billion INR | 40.031% |
| Alpa Laboratories Limited | 188.89 Million INR | -2453.424% |
| Lasa Supergenerics Limited | 121.02 Million INR | -3885.202% |
| Sun Pharma Advanced Research Company Limited | 391.06 Million INR | -1133.37% |